• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于二硫键化坏死和铁死亡的乳腺癌患者预后分层

Prognosis stratification of patients with breast cancer based on disulfidptosis and ferroptosis.

作者信息

Yang Xuemei, Wang Yifan

机构信息

Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.

出版信息

Medicine (Baltimore). 2025 Apr 18;104(16):e42146. doi: 10.1097/MD.0000000000042146.

DOI:10.1097/MD.0000000000042146
PMID:40258757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12014030/
Abstract

Disulfidptosis and ferroptosis, recently identified patterns of programmed cell death, play pivotal roles in the progression of breast cancer. This study aimed to explore the potential of disulfidptosis and ferroptosis in the prognostic stratification of Breast Cancer. Correlation analysis, Least Absolute Shrinkage and Selection Operator (LASSO) regression algorithm, univariate and multivariate Cox regression analyses were performed to identify the core long non-coding RNAs associated with disulfidptosis and ferroptosis. A risk signature and a prognostic nomogram were constructed based on these findings. Additionally, investigations concerning functional pathways, mutation landscapes, immune infiltration, and drug sensitivity were conducted in different risk stratification groups. Machine learning analyses revealed a risk signature comprising seven long non-coding RNAs closely associated with disulfidptosis and ferroptosis. Validated in two datasets, breast cancer patients with high-risk scores exhibited a poorer prognosis. The prognostic nomogram, integrating the risk signature with age and TNM stage, demonstrated a favorable predictive capability for survival outcomes. Furthermore, the high-risk group showed a higher tumor mutation burden compared to the low-risk group, which was also characterized by immune suppression and sensitivity to cisplatin, lapatinib and olaparib. Our study highlights the crucial role of disulfidptosis and ferroptosis in guiding clinical decision-making for patients with breast cancer, which also characterizes the intricate landscape of breast cancer and deepens our understanding of tumor heterogeneity.

摘要

二硫化物诱导的细胞死亡和铁死亡是最近发现的程序性细胞死亡模式,在乳腺癌进展中起关键作用。本研究旨在探讨二硫化物诱导的细胞死亡和铁死亡在乳腺癌预后分层中的潜力。进行了相关性分析、最小绝对收缩和选择算子(LASSO)回归算法、单因素和多因素Cox回归分析,以确定与二硫化物诱导的细胞死亡和铁死亡相关的核心长链非编码RNA。基于这些发现构建了风险特征和预后列线图。此外,还对不同风险分层组的功能途径、突变图谱、免疫浸润和药物敏感性进行了研究。机器学习分析揭示了一个由七个与二硫化物诱导的细胞死亡和铁死亡密切相关的长链非编码RNA组成的风险特征。在两个数据集中得到验证,高风险评分的乳腺癌患者预后较差。将风险特征与年龄和TNM分期相结合的预后列线图对生存结果显示出良好的预测能力。此外,高风险组与低风险组相比显示出更高的肿瘤突变负担,其特征还包括免疫抑制以及对顺铂、拉帕替尼和奥拉帕尼敏感。我们的研究强调了二硫化物诱导的细胞死亡和铁死亡在指导乳腺癌患者临床决策中的关键作用,这也描绘了乳腺癌的复杂图景并加深了我们对肿瘤异质性的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/95ab374f0c40/medi-104-e42146-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/e151a29df455/medi-104-e42146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/8e0c645b1714/medi-104-e42146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/13cfd01f31b5/medi-104-e42146-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/42588277d801/medi-104-e42146-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/ed20170467e5/medi-104-e42146-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/d56ad07175ec/medi-104-e42146-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/2bd2e2ad3ca6/medi-104-e42146-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/95ab374f0c40/medi-104-e42146-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/e151a29df455/medi-104-e42146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/8e0c645b1714/medi-104-e42146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/13cfd01f31b5/medi-104-e42146-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/42588277d801/medi-104-e42146-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/ed20170467e5/medi-104-e42146-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/d56ad07175ec/medi-104-e42146-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/2bd2e2ad3ca6/medi-104-e42146-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/925d/12014030/95ab374f0c40/medi-104-e42146-g008.jpg

相似文献

1
Prognosis stratification of patients with breast cancer based on disulfidptosis and ferroptosis.基于二硫键化坏死和铁死亡的乳腺癌患者预后分层
Medicine (Baltimore). 2025 Apr 18;104(16):e42146. doi: 10.1097/MD.0000000000042146.
2
Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature.基于二硫键连接的铁死亡相关特征建立子宫体子宫内膜癌的预后特征及免疫浸润特征
Front Immunol. 2025 Jan 27;16:1492541. doi: 10.3389/fimmu.2025.1492541. eCollection 2025.
3
Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity.基于半胱氨酸代谢-二硫键凋亡亲和力的乳腺浸润性癌患者预后分层。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11979-11994. doi: 10.1007/s00432-023-05028-y. Epub 2023 Jul 8.
4
A novel disulfidptosis-related LncRNA prognostic risk model: predicts the prognosis, tumor microenvironment and drug sensitivity in esophageal squamous cell carcinoma.一个新的与二硫键相关的长链非编码 RNA 预后风险模型:预测食管鳞状细胞癌的预后、肿瘤微环境和药物敏感性。
BMC Gastroenterol. 2024 Nov 27;24(1):437. doi: 10.1186/s12876-024-03530-2.
5
Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.基于与二硫键凋亡、铜死亡和铁死亡相关基因的机器学习和 WGCNA 双重分析构建和验证乳腺癌预后模型。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16511-16523. doi: 10.1007/s00432-023-05378-7. Epub 2023 Sep 15.
6
Identification of a PANoptosis-related long noncoding rna risk signature for prognosis and immunology in colon adenocarcinoma.鉴定一种与全凋亡相关的长链非编码RNA风险特征用于预测结肠腺癌的预后和免疫情况
BMC Cancer. 2025 Apr 10;25(1):662. doi: 10.1186/s12885-025-14021-2.
7
Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.开发一种新型的与二硫键错配相关的 lncRNA 标志物,用于预测透明细胞肾细胞癌的预后和免疫反应。
Sci Rep. 2024 Jan 5;14(1):624. doi: 10.1038/s41598-024-51197-2.
8
Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma.基于机器学习的二硫键相关 lncRNA 特征可预测肝细胞癌的预后、免疫浸润和药物敏感性。
Sci Rep. 2024 Feb 22;14(1):4354. doi: 10.1038/s41598-024-54115-8.
9
Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinoma.二硫化物诱导细胞程序性坏死相关免疫基因推动膀胱尿路上皮癌预后模型的建立及肿瘤微环境特征分析
Sci Rep. 2025 Mar 8;15(1):8130. doi: 10.1038/s41598-025-92297-x.
10
Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration.与二硫化物诱导的细胞死亡相关的铁死亡相关基因风险模型在肝细胞癌预后和免疫浸润中的新应用
PeerJ. 2024 Feb 2;12:e16819. doi: 10.7717/peerj.16819. eCollection 2024.

本文引用的文献

1
Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma.二硫键相关长非编码 RNA 特征可预测结肠腺癌的预后、肿瘤微环境、免疫治疗和抗肿瘤药物选择。
Apoptosis. 2024 Dec;29(11-12):2074-2090. doi: 10.1007/s10495-024-02011-x. Epub 2024 Aug 8.
2
Crosstalk among disulfidptosis-related lncRNAs in lung adenocarcinoma reveals a correlation with immune profile and clinical prognosis.肺腺癌中与二硫化物诱导细胞程序性坏死相关的长链非编码RNA之间的相互作用揭示了其与免疫特征和临床预后的相关性。
Noncoding RNA Res. 2024 Mar 20;9(3):772-781. doi: 10.1016/j.ncrna.2024.03.006. eCollection 2024 Sep.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinoma.二硫键相关长非编码 RNA 特征可评估肝癌的免疫微环境和药物敏感性。
Comput Biol Med. 2024 Feb;169:107930. doi: 10.1016/j.compbiomed.2024.107930. Epub 2024 Jan 4.
5
Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma.利用与铁死亡相关的长链非编码RNA特征预测胶质瘤的预后和免疫治疗
Cancer Cell Int. 2023 Dec 8;23(1):316. doi: 10.1186/s12935-023-03147-7.
6
LncFASA promotes cancer ferroptosis via modulating PRDX1 phase separation.LncFASA 通过调节 PRDX1 的相分离促进癌症的铁死亡。
Sci China Life Sci. 2024 Mar;67(3):488-503. doi: 10.1007/s11427-023-2425-2. Epub 2023 Nov 10.
7
NK cell-based tumor immunotherapy.基于自然杀伤细胞的肿瘤免疫疗法。
Bioact Mater. 2023 Aug 9;31:63-86. doi: 10.1016/j.bioactmat.2023.08.001. eCollection 2024 Jan.
8
Integrative models of histopathological images and multi-omics data predict prognosis in endometrial carcinoma.整合组织病理学图像和多组学数据的模型预测子宫内膜癌的预后。
PeerJ. 2023 Aug 11;11:e15674. doi: 10.7717/peerj.15674. eCollection 2023.
9
Disulfidptosis: disulfide stress-induced cell death.二硫键程序性细胞死亡:二硫键应激诱导的细胞死亡。
Trends Cell Biol. 2024 Apr;34(4):327-337. doi: 10.1016/j.tcb.2023.07.009. Epub 2023 Aug 12.
10
The therapeutic potential of targeting regulated non-apoptotic cell death.靶向调控非细胞凋亡性细胞死亡的治疗潜力。
Nat Rev Drug Discov. 2023 Sep;22(9):723-742. doi: 10.1038/s41573-023-00749-8. Epub 2023 Aug 7.